Positive prostate biopsy laterality and implications for staging

Urology

Volumn 62, Issue 2, 2003, Pages 298-303

  Buyyounouski, Mark K ^a   Horwitz, Eric M ^a   Hanlon, Alexandra L ^a   Uzzo, Robert G ^a   Hanks, Gerald E ^a   Pollack, Alan ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PALPATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

EID: 0042624704     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00334-0     Document Type: Article

References (26)

1. Prostate. Greene F.L., Fleming I.D., Fritz A.G., et al. AJCC Cancer Staging Manual. 2002;309-316 Lippincott Raven, Philadelphia.
2. Prostate. Sobin L.H. UICC TNM Classification of Malignant Tumours. 2002;184-187 Wiley-Liss, New York.
3. Prostate. Fleming I., Cooper J., Henson D., et al. AJCC Cancer Staging Manual. 1997;219-224 Lippincott-Raven, Philadelphia.
4. Liebross R.H., Pollack A., Lankford S.P., et al. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy. Urology. 52:1998;647-652.
5. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology. 55:2000;572-577.
6. Grossklaus D.J., Coffey C.S., Shappell S.B., et al. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol. 167:2002;2032-2036.
7. Ravery V., Chastang C., Toublanc M., et al. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol. 37:2000;449-455.
8. Tigrani V.S., Bhargava V., Shinohara K., et al. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology. 54:1999;689-693.
9. Horwitz E.M., Hanlon A.L., Pinover W.H., et al. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Cancer. 92:2001;1281-1287.
10. Monti A.F., Ostinelli A., Frigerio M., et al. An ICRU 50 radiotherapy treatment chart. Radiother Oncol. 35:1995;145-150.
11. Cox JD, Grignon DJ, Kaplan RS, et al, for the American Society for Therapeutic Radiology and Oncology Consensus Panel: Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997.
12. Cox G. Regression models and life tables. J Roy Stat Soc. 34:1972;187-220.
13. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics. 11:1955;275-386.
14. American Joint Committee on Cancer Staging and End Results Reporting: Prostate: Manual for Staging of Cancer, 1977. Chicago, 1977, pp 119-142.
15. Prostate. Beahrs O., Henson D.E., Hutter R.V., et al. Manual for Staging of Cancer. 1988;177-179 Lippincott, Philadelphia.
16. Prostate. Beahrs O., Henson D.E., Hutter R.V., et al. Manual for the Staging of Cancer. 1992;181-183 Lippincott, Philadelphia.
17. Coen J.J., Zietman A.L., Thakral H., et al. Radical radiation for localized prostate cancer local persistence of disease results in a late wave of metastases . J Clin Oncol. 20:2002;3199-3205.
18. Kupelian P.A., Buchsbaum J.C., Patel C., et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys. 52:2002;704-711.
19. Pollack A., Hanlon A.L., Movsas B., et al. Correlates of distant metastasis and death in prostate cancer patients treated with radiotherapy. Int J Rad Oncol Biol Phys. 54:(2):2002;11-12.
20. Liebross R.H., Pollack A., Lankford S.P., et al. Transrectal ultrasound for staging prostate carcinoma prior to radiation therapy an evaluation based on disease outcome . Cancer. 85:1999;1577-1585.
21. Pinover W.H., Hanlon A., Lee W.R., et al. Prostate carcinoma patients upstaged by imaging and treated with irradiation an outcome-based analysis . Cancer. 77:1996;1334-1341.
22. D'Amico A.V., Whittington R., Malkowicz B., et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol. 164:2000;759-763.
23. D'Amico A.V., Schultz D., Silver B., et al. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 49:2001;679-684.
24. Iyer R.V., Hanlon A.L., Pinover W.H., et al. Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy. Cancer. 85:1999;1816-1821.
25. Zagars G.K., Geara F.B., Pollack A., et al. The T classification of clinically localized prostate cancer an appraisal based on disease outcome after radiation therapy . Cancer. 73:1994;1904-1912.
26. Smith E.B., Frierson H.F. Jr, Mills S.E., et al. Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years is there evidence for systematic upgrading? Cancer. 94:2002;2282-2287.